Literature DB >> 7475660

Multiple introductions of HIV-1 subtype E into the western hemisphere.

A W Artenstein1, J Coppola, A E Brown, J K Carr, E Sanders-Buell, E Galbarini, J R Mascola, T C VanCott, P Schonbrood, F E McCutchan.   

Abstract

There are nine recognised genetic subtypes of HIV-1, and the epidemic in Southeast Asia is largely due to subtype E. We have investigated HIV-1 viral subtypes in 11 Uruguayan military personnel, six with infection acquired during a United Nations deployment to Cambodia and five with infection acquired in South America. We found subtype E in five of the six infections acquired in Southeast Asia, and subtype B in all five of the domestically acquired cases. These findings document multiple introductions of HIV-1 subtype E into the western hemisphere and mean that the genetic diversity of the global HIV-1 pandemic must be considered in strategies for epidemic control.

Entities:  

Keywords:  Americas; Asia; Cambodia; Developing Countries; Diseases; Examinations And Diagnoses; Genetic Technics; Government; Hiv Infections--transmission; Laboratory Examinations And Diagnoses; Latin America; Military Personnel; Political Factors; Research Report; South America; Southeastern Asia; Thailand; Uruguay; Viral Diseases

Mesh:

Year:  1995        PMID: 7475660     DOI: 10.1016/s0140-6736(95)92900-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  9 in total

1.  Simian-human immunodeficiency virus containing a human immunodeficiency virus type 1 subtype-E envelope gene: persistent infection, CD4(+) T-cell depletion, and mucosal membrane transmission in macaques.

Authors:  S Himathongkham; N S Halpin; J Li; M W Stout; C J Miller; P A Luciw
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Integrating laboratory and epidemiological techniques for population-based surveillance of HIV strains and drug resistance in Canada.

Authors:  G C Jayaraman; C P Archibald; L Lior; D Sutherland
Journal:  Can J Infect Dis       Date:  2000-03

3.  The Honduran human immunodeficiency virus type 1 (HIV-1) epidemic is dominated by HIV-1 subtype B as determined by V3 domain sero- and genotyping.

Authors:  C Lara; M Sällberg; B Johansson; I L de Rivera; A Sönnerborg
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

Review 4.  Recurrent CDC group IVc-2 bacteremia in a human with AIDS.

Authors:  R R Anderson; P Warnick; P C Schreckenberger
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

5.  Induction of neutralizing antibodies to T-cell line-adapted and primary human immunodeficiency virus type 1 isolates with a prime-boost vaccine regimen in chimpanzees.

Authors:  S Zolla-Pazner; M Lubeck; S Xu; S Burda; R J Natuk; F Sinangil; K Steimer; R C Gallo; J W Eichberg; T Matthews; M Robert-Guroff
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

6.  Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand.

Authors:  J K Carr; M O Salminen; C Koch; D Gotte; A W Artenstein; P A Hegerich; D St Louis; D S Burke; F E McCutchan
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

7.  Diversity of the envelope glycoprotein among human immunodeficiency virus type 1 isolates of clade E from Asia and Africa.

Authors:  F E McCutchan; A W Artenstein; E Sanders-Buell; M O Salminen; J K Carr; J R Mascola; X F Yu; K E Nelson; C Khamboonruang; D Schmitt; M P Kieny; J G McNeil; D S Burke
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

8.  The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin.

Authors:  F Gao; D L Robertson; S G Morrison; H Hui; S Craig; J Decker; P N Fultz; M Girard; G M Shaw; B H Hahn; P M Sharp
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

Review 9.  Roles and functions of HIV-1 Tat protein in the CNS: an overview.

Authors:  Asen Bagashev; Bassel E Sawaya
Journal:  Virol J       Date:  2013-12-21       Impact factor: 4.099

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.